Patient #31 had a diagnosis of HR-positive, HER2-negative early BC subjected to mastectomy and hormonotherapy; she was CTC-negative before surgery, and six months after surgery she presented 1 CTC. This evidence concerns the gene ERBB2 and breast cancer.